Evidence map›Paper›PMID 29164065›Full record

ReviewFrontiers in oncology2017

Transcriptional and Microenvironmental Regulation of Lineage Ambiguity in Leukemia.

Tianyuan Hu, Rebecca Murdaugh, Daisuke Nakada

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Myeloid lineage switch inHaematologica · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tianyuan HuDepartment of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX, United States.
Rebecca MurdaughProgram in Developmental Biology, Baylor College of Medicine, Houston, TX, United States.
Daisuke NakadaDepartment of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX, United States.

Funding

METABOLIC REGULATION IN LEUKEMIA-INITIATING CELLSR01CA193235 · NCI · BAYLOR COLLEGE OF MEDICINE · PI NAKADA, DAISUKE · 2015 to 2024
$4.6M
Mesenchymal Stromal Cells Regulate Hematopoietic Stem Cell AgingR01DK107413 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI NAKADA, DAISUKE · 2016 to 2020
$2.2M
NCI NIH HHS R01 CA193235NIDDK NIH HHS R01 DK107413
6 · The paper itself

Abstract

Leukemia is characterized by the uncontrolled production of leukemic cells and impaired normal hematopoiesis. Although the combination of chemotherapies and hematopoietic stem cell transplantation has significantly improved the outcome of leukemia patients, a proportion of patients still suffer from relapse after treatment. Upon relapse, a phenomenon termed "lineage switch" is observed in a subset of leukemia patients, in which conversion of lymphoblastic leukemia to myeloid leukemia or

Indexed as

acute lymphoid leukemiaacute myeloid leukemiaCAR-T cellshematopoietic stem cellslineage switch leukemiamixed-phenotype acute leukemia

Identifiers

PMID29164065
PMCPMC5681738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.